# US 4,391,911 A · Preparation of herpes simplex antigen for the diagnosis of carcinoma > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 4,391,911 A - Document ID: US4391911A - Status: Granted - Kind: A - Application number: 06/115,375 - Filed: 1980-01-25 - Granted: 1983-07-05 - Earliest claimed: 1979-05-18 - Assignees: Depa S.p.A. - Inventors: Giulio Tarro - Web page: https://patentgrep.com/patent/US4391911A ## CPC - G01N 33/56994: {Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus} - G01N 2474/20: Immunohistochemistry assay - Y10S 435/803: Physical recovery methods, e.g. chromatography, grinding - Y10S 436/813: Cancer - Y10S 530/806: Antigenic peptides or proteins - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) - Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS ## Abstract The invention relates to a process for the industrial production of a product for the diagnosis of carcinoma consisting of an antigen obtained by the infection with Herpes Simplex Virus of cells of guinea-pig kidney, the process comprising three main sections, in the first of which the antigen is produced, in the second section a biochemical purification of the antigen is carried out, while in the third section the product is prepared in preservable condition and confection. ## Claims ### Claim 1 A process for the industrial production of a non-virion antigen of the Herpes simplex virus for the diagnosis of the epithelial tissue tumors or carcinoma, in which the cells to be infected by the antigen are prepared starting from the guinea pig kidneys with the addition to said material of sterile trypsin and a culture medium consisting of lactoalbumin and calf serum, comprising the steps of: (i) growing the cells with a dynamic system inside Spinner flasks provided with magnetic revolving stirrers rotating at speeds higher than about 50 r.p.m. and operating at a temperature of 37.degree. C. and with successive additions of culture medium, inoculating the so obtained cells with Herpes simplex virus to with added culture medium, said infection phase being performed according to a volume ratio of the virus to the cells equal or higher than 1, but not higher than 100, the contact between the cells and the virus being maintained for about 3 hours; and collecting the antigen which is formed therein; (ii) purifying the collected antigen, by removing therefrom all the proteins and impurities which can negatively affect the tests for the diagnosis; comprising, a first centrifugation with recovery of the liquid phase from the first centrifugation step; precipitating the antigen protein and other proteins, a second centrifugation; diluting the residual solids from the second contrifugation using a buffer; purifying said diluted solids by molecular separation using organic gellified copolymers extraction column, collecting the proteins from the antigen purification on a column wherein the proteins are separated on the basis of their different electric charges; eluting said collected proteins and removing the non-glycosilated proteins by affinity chromatography on a column; and recovering purified antigens. ### Claim 2 (depends on 1) A process according to claim 1, wherein the culture medium for the cell growth as in step (i) is previously subjected to sterility tests, the growth being performed in macrothermostats at a temperature of 37.degree. C. ### Claim 3 (depends on 1) A process according to claim 1, wherein the culture medium in step (i) is Basal Medium Eagle. ### Claim 4 (depends on 1) A process according to claim 1, wherein the buffer used in the preparatory purification operation in step (ii) is Tris-HCl 20 mM (pH=7.2) which is added in the proportion of 40% by volume. ### Claim 5 (depends on 1) A process according to claim 1, wherein the buffer used for the second centrifugation in step (ii) is Tris-HCl 20 mM (pH=7.2). ### Claim 6 (depends on 1) A process according to claim 1, wherein the resin which is used for the molecular separation of the proteins is an organic gelified polymer having electric surface charges. ### Claim 7 (depends on 1) A process according to claim 1, wherein for the separation of proteins on the basis of different electric charges an organic gelified copolymer having electric surface charges is used. ### Claim 8 (depends on 1) A process according to claim 1, wherein for the elimination of the non-glycosilated proteins, in step (ii) an organic gelified copolymer having electric surface charges is used which is bound to Concanavalin A. ### Claim 9 (depends on 1) The process according to claim 1, wherein the step ii eluent comprises Tris-HCl 20 mM+NaCl and said elution step is followed by removal of the NaCl. ### Claim 10 (depends on 1) The process according to claim 1, wherein said step ii removal of non-glycosilated proteins is carried out by adding glucidic substance, alpha-methyl-D mannoside in a 3% water solution and following elution, removing said glucidic substance. ### Claim 11 A method of producing antigens for detecting tumors comprising the steps of: (a) dynamically growing cells in a suitable culture media comprising lactoalbumin and calf serum; (b) innoculating said cells with Herpes simplex virus in a volume ratio of virus to cells ranging from 1 to 100 to form antigen; (c) separating the proteins containing said antigens from the remaining proteins according to molecular weight in a resin-containing chromatographic column; and (d) further separating said antigen containing proteins in a column according to the electrical charges; (e) collecting the concentrated purified antigen; (f) introducing said antigens into bottles in predetermined dosages and in a preserved state for use. ### Claim 12 (depends on 11) The method of claim 11, wherein Guinea pig kidney is the starting material for innoculation with said virus. ### Claim 13 (depends on 12) The method of claim 12, wherein said innoculation step includes stirring for a time and in a speed sufficient to ensure adequate contact time between tissue cells and virus.